Detalhe da pesquisa
1.
Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies.
Semin Nucl Med
; 32(2): 123-32, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11965607
2.
Peptide receptor radionuclide therapy with 177Lu-DOTATATE for patients with somatostatin receptor-expressing neuroendocrine tumors: the first US phase 2 experience.
Pancreas
; 43(4): 518-25, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24632546
3.
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.
Theranostics
; 2(5): 472-80, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22737186